Home > Insider Trading > Filing (0000950170-24-107844)

Filing Details

Accession Number:: 0000950170-24-107844
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-18 16:53:07
Reporting Period:: 2024-09-16

Accepted Time:: 2024-09-18 16:53:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1861560	Nuvalent Inc.	NUVL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2029477	E. Henry Pelish	C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2024-09-16	1,966	$93.25	64,129	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	3,754	$94.80	60,375	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	1,548	$95.36	58,827	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	4,105	$96.61	54,722	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	3,197	$97.54	51,525	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	706	$98.22	50,819	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	4,094	$100.25	46,725	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	5,513	$101.18	41,212	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	7,812	$102.54	33,400	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-16	100	$102.80	33,300	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.02 to $93.69, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (10) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.10 to $95.09, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.13 to $96.05, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.17 to $97.14, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.18 to $98.12, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.19 to $99.01, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.69 to $100.58, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.74 to $101.67, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.76 to $102.73, inclusive.